| 臺大學術典藏 |
2020-06-22T07:37:15Z |
Decreased expressions of hepsin in human hepatocellular carcinomas
|
Chen C.-H.;Su K.-Y.;Tao M.-H.;Shu-Wha Lin;Su Y.-H.;Tsai Y.-C.;Cheng K.-C.;Jeng Y.-M.;Sheu J.-C.; Chen C.-H.; Su K.-Y.; Tao M.-H.; SHU-WHA LIN; Su Y.-H.; Tsai Y.-C.; Cheng K.-C.; Jeng Y.-M.; Sheu J.-C. |
| 臺大學術典藏 |
2020-06-11T06:14:39Z |
Highly Sensitive Graphene-Semiconducting Polymer Hybrid Photodetectors with Millisecond Response Time
|
Chang, P.-H.;Tsai, Y.-C.;Shen, S.-W.;Liu, S.-Y.;Huang, K.-Y.;Li, C.-S.;Chang, H.-P.;Wu, C.-I.; Chang, P.-H.; Tsai, Y.-C.; Shen, S.-W.; Liu, S.-Y.; Huang, K.-Y.; Li, C.-S.; Chang, H.-P.; Wu, C.-I.; CHIH-I WU |
| 臺大學術典藏 |
2020-05-27T03:38:19Z |
The genetic structure, virulence, and fungicide sensitivity of Fusarium fujikuroi in Taiwan
|
Chen Y.-C.; Lai M.-H.; CHIA-YI WU; Lin T.-C.; Cheng A.-H.; Yang C.-C.; Wu H.-Y.; Chu S.-C.; Kuo C.-C.; Wu Y.-F.; Lin G.-C.; Tseng M.-N.; Tsai Y.-C.; Lin C.-C.; Chen C.-Y.; Huang J.-W.; Lin H.-A.; Chung C.-L. |
| 臺大學術典藏 |
2020-05-26T09:27:25Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Lin C.-C;Yeh K.-H;Chih-Hsin Yang;Hsu C;Tsai Y.-C;Hsu W.-L;Cheng A.-L;Hsu C.-H.; Lin C.-C; Yeh K.-H; CHIH-HSIN YANG; Hsu C; Tsai Y.-C; Hsu W.-L; Cheng A.-L; Hsu C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:33Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Keng H.-Y; Tsai Y.-C; Huang K.-H; Cheng A.-L; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:33Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Tsai Y.-C; Huang K.-H; Cheng A.-L; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:32Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
Hsu C.-H.;Cheng A.-L;Hsu W.-L;Tsai Y.-C;Hsu C;Yang C.-H;Yeh K.-H;Chia-Chi Lin; Chia-Chi Lin; Yeh K.-H; Yang C.-H; Hsu C; Tsai Y.-C; Hsu W.-L; Cheng A.-L; Hsu C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:31Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Cheng J.C.-H.;Lee Y.-C;Tsai Y.-C;Hsu C.-H;Chang Y.-L;Lee J.-M;Chia-Chi Lin;Hsu F.-M; Hsu F.-M; Chia-Chi Lin; Lee J.-M; Chang Y.-L; Hsu C.-H; Tsai Y.-C; Lee Y.-C; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:29Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Hsu F.-M; Lee Y.-C; Lee J.-M; Hsu C.-H; Chia-Chi Lin; Tsai Y.-C; Wu J.-K; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:29Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Huang C.-Y; Cheng J.C; Chia-Chi Lin; Hsu C.-H; Tsai Y.-C; Hsu F.-M; Huang K.-H; Cheng A.-L; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T07:35:27Z |
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma
|
Tsai Y.-C; Hsu C.-H; Chia-Chi Lin; Hsu F.-M; Lee J.-M; Huang P.-M; Lee Y.-C; Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2020-05-25T07:35:15Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang Y; Cheng J.C.-H; Huang C.-Y; Tsai Y.-C; Chia-Chi Lin; Hsu C.-H; Cheng A.-L; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T02:46:13Z |
Knockdown of RyR3 enhances adiponectin expression through an atf3-dependent pathway
|
Tsai S.-H.;Chang E.Y.-C.;Chang Y.-C.;Hee S.-W.;Tsai Y.-C.;Tien-Jyun Chang;Chuang L.-M.; Tsai S.-H.; Chang E.Y.-C.; Chang Y.-C.; Hee S.-W.; Tsai Y.-C.; TIEN-JYUN CHANG; Chuang L.-M. |
| 臺大學術典藏 |
2020-05-25T02:45:41Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Cheng J.C.-H.; Lee Y.-C; Tsai Y.-C; Hsu C.-H; Feng-Ming Hsu; Lin C.-C; Lee J.-M; Chang Y.-L |
| 臺大學術典藏 |
2020-05-25T02:45:40Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C; Hsu C.-H; Cheng J.C; Huang C.-Y; Tsai Y.-C; Feng-Ming Hsu; Huang K.-H; Cheng A.-L; Pu Y.-S. |
| 臺大學術典藏 |
2020-05-25T02:45:40Z |
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma
|
Feng-Ming Hsu;Lee J.-M;Huang P.-M;Lin C.-C;Hsu C.-H;Tsai Y.-C;Lee Y.-C;Chia-Hsien Cheng J.; Feng-Ming Hsu; Lee J.-M; Huang P.-M; Lin C.-C; Hsu C.-H; Tsai Y.-C; Lee Y.-C; Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2020-05-25T02:45:33Z |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Feng-Ming Hsu; Hou W.-H; Huang C.-Y; Wang C.-C; Tsai C.-L; Tsai Y.-C; Yu H.-J; Pu Y.-S; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-05-25T02:45:21Z |
Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells
|
Tien Y; Tsai C.-L; Hou W.-H; Chiang Y; Feng-Ming Hsu; Tsai Y.-C; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:32Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Pu Y.-S.;Cheng A.-L.;Huang K.-H.;Tsai Y.-C.;Huang C.-Y.;CHIH-HUNG HSU;Lin C.-C.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:31Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
CHIH-HUNG HSU;Cheng A.-L.;Hsu W.-L.;Tsai Y.-C.;Hsu C.;Yang C.-H.;Yeh K.-H.;Lin C.-C.; Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2020-04-28T07:25:30Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Lin C.-C.; Lee J.-M.; Chang Y.-L.; CHIH-HUNG HSU; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H.; Cheng J.C.-H.;Lee Y.-C.;Tsai Y.-C.;CHIH-HUNG HSU;Chang Y.-L.;Lee J.-M.;Lin C.-C.;Hsu F.-M.; Hsu F.-M. |
| 臺大學術典藏 |
2020-04-28T07:25:28Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Hsu F.-M.;Lee Y.-C.;Lee J.-M.;Chih-Hung Hsu;Lin C.-C.;Tsai Y.-C.;Wu J.-K.;Cheng J.C.-H.; Hsu F.-M.; Lee Y.-C.; Lee J.-M.; CHIH-HUNG HSU; Lin C.-C.; Tsai Y.-C.; Wu J.-K.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:28Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.; CHIH-HUNG HSU; Lin C.-C.;Chih-Hung Hsu;Cheng J.C.;Huang C.-Y.;Tsai Y.-C.;Hsu F.-M.;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:25Z |
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma
|
Huang P.-M.; Lee J.-M.; Hsu F.-M.; Hsu F.-M. ;Lee J.-M. ;Huang P.-M. ;Lin C.-C. ;Chih-Hung Hsu ;Tsai Y.-C. ;Lee Y.-C. ;Chia-Hsien Cheng J.; Lin C.-C.; CHIH-HUNG HSU; Tsai Y.-C.; Lee Y.-C.; Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2020-04-28T07:25:14Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Tsai Y.-C.; Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Chih-Hung Hsu;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; Lin C.-C.; CHIH-HUNG HSU; Cheng A.-L.; Pu Y.-S. |
